Advertisement Aesculap to distribute Misonix BoneScalpel - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aesculap to distribute Misonix BoneScalpel

Medical device company Misonix has entered into a distribution agreement with Aesculap, a subsidiary of B Braun, for the domestic distribution of the Misonix BoneScalpel, a new bone-cutting device for use in orthopedic and neurological applications related to the spine and cranium.

The agreement provides Aesculap with the right to sell in the US and includes minimum purchase requirements and the payment of a royalty on sales of disposables.

Michael McManus, Jr, president and CEO of Misonix, said: “We have been working with Aesculap for many years in the distribution of our Sonastar ultrasonic aspirator for neurosurgery and know them to be true professionals that understand the market, particularly for technologically enhanced medical devices. The opportunity to sell the Sonastar and the BoneScalpel together will create additional leverage in the market that will be a benefit to both companies.”